Log In
BCIQ
Print this Print this
 

IFX-2

  Manage Alerts
Collapse Summary General Information
Company InflaRx GmbH
DescriptionHuman mAb
Molecular Target
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPreclinical
Standard IndicationInflammatory disease
Indication DetailsTreat chronic inflammatory diseases; Treat sub-acute inflammatory diseases
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today